HilleVax, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 46.83 million compared to USD 26.89 million a year ago. Basic loss per share from continuing operations was USD 0.97 compared to USD 0.71 a year ago.

Diluted loss per share from continuing operations was USD 0.97 compared to USD 0.71 a year ago.